Fr1da Insulin Intervention
Mechanistic Study Using Oral Insulin for Immune Efficacy in Secondary Prevention of Type 1 Diabetes
Sponsor: Helmholtz Zentrum München
A PHASE2 clinical study on Stage 1 Diabetes Mellitus, Type 1, this trial is completed. The trial is conducted by Helmholtz Zentrum München and has accumulated 14 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Nov 2024 — Present [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Dec 2022 — Oct 2023 [monthly]
Active Not Recruiting PHASE2
▶ Show 9 earlier versions
-
Nov 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE2
-
Sep 2021 — Nov 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Aug 2019 — Nov 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Mar 2018 [monthly]
Recruiting PHASE2
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Helmholtz Zentrum München
- Ludwig-Maximilians - University of Munich
- Technical University of Munich
- Technische Universität Dresden
For direct contact, visit the study record on ClinicalTrials.gov .